Delving into the Latest Updates on Ankara University with Synapse

Overview

Lomber dorsal root ganglion pRF is an interventional treatment options in the treatment of lumbar radicular pain. The goal of this study is to investigate the effect of sensory threshold outcomes on pain severity during dorsal root ganglion pulsed radiofrequency (DRG-pRF). It will also learn effects about disability due to chronic LRP. The main questions it aims to answer are:
Does lower sensory threshold result in lower pain scores and chronic LRP related disability?
Participants will:
Take DRG-pRF procedure for 4 minutes. Visit the clinic at 1. and 3. month for questionnaries.

Start Date01 Jan 2025

Sponsor / Collaborator

Ankara University

NCT06775444

/ Not yet recruitingNot ApplicableIIT

The Effect Of The Theory Of Planned Behavior Based Breastfeeding Education Program Given To Pregnant Women On Breastfeedıng Adaptation, Motivation, Self-Efficacy And The Tendency To Early Weaning.

The aim of the research is to examine the effect of a breastfeeding training program based on the theory of planned behavior on Pregnant Womens' Breastfeeding Adaptation, Motivation, Self-Efficacy And The Tendency To Early Weaning.

Start Date01 Jan 2025

Sponsor / Collaborator

Ankara University

100 Clinical Results associated with Ankara University

Login to view more data

0 Patents (Medical) associated with Ankara University

Login to view more data

33,335

Literatures (Medical) associated with Ankara University

31 Dec 2025·Geomatics, Natural Hazards and Risk

Determination of Anatolian Plate’s tectonic block boundaries with clustering analysis using GNSS sites velocities

Author: Aktuğ, Bahadır ; Şafak Yaşar, Şeyma ; Tiryakioğlu, İbrahim ; Özkaymak, Çağlar ; Erdoğan, Hediye

01 Dec 2025·Journal of Gastrointestinal Cancer

Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis

Article

Author: Akyol, Cihangir ; Savaş, Berna ; Karaoğlan, Beliz Bahar ; Utkan, Güngör ; Öztürk, İremsu

BACKGROUNDTumor deposits (TDs) are known to have a poor prognosis independent of lymph node (LN) involvement and are considered equivalent to LN metastases in the latest staging system. In stage III colon cancer (CC), high-risk patients (pT4 or pN2) receive 6 months of adjuvant chemotherapy, while low-risk patients (pT1-3 and N1) are recommended either 3 or 6 months of CAPOX or 6 months of FOLFOX therapy. However, the optimal chemotherapy duration for low-risk patients classified as pN1c remains unknown. The aim of this study is to investigate the impact of adjuvant chemotherapy duration (3 months vs. 6 months) on survival in patients with low-risk stage III CC either in pN1a-b and pN1c patient groups.METHODSWe retrospectively analyzed patients with stage III CC who underwent surgery at a tertiary center between January 2014 and May 2024. Demographic and pathological data of patients were retrospectively collected. The primary outcome was disease-free survival (DFS).RESULTSA total of 142 patients were included. Among the patients, 116 were pT1-3N1a-b and 26 were pT1-3N1c. Local (23.1% vs. 1.7%, P < 0.001) and overall (38.5% vs 14.6%, P = 0.011) recurrences were significantly higher in the pN1c group. Univariate and multivariate analyses revealed no significant impact of adjuvant chemotherapy duration on DFS in the pN1a-b group (P = 0.359), whereas in the pN1c group, 3-month chemotherapy resulted in significantly shorter DFS (P = 0.044) in univariate analysis.CONCLUSIONOur study indicates that shorter duration of adjuvant chemotherapy is associated with worse survival and 6-month chemotherapy is recommended for patients with pT1-3 and N1c disease.

01 Dec 2025·Journal of Clinical Immunology

Correction to: DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans

Author: Azizoglu, Zehra Busra ; Ozcan, Alper ; Baris, Safa ; Leblebici, Can Berk ; Özen, Ahmet ; Ayaz-Guner, Serife ; Basaran, Kemal Erdem ; Ikinciogullari, Aydan ; Canatan, Mehmed Fatih ; Alsavaf, Mohammad Bilal ; Eken, Ahmet ; Canoz, Ozlem ; Unal, Ekrem ; Dogu, Figen ; Karakoc-Aydiner, Elif ; Per, Huseyin ; Kose, Mehmet ; Erkmen, Hasret ; Karakukcu, Musa ; Okus, Fatma Zehra ; Gümüş, Gülsüm ; Canatan, Halit ; Ozcan, Servet ; Babayeva, Royala ; Ceylaner, Serdar ; Can, Salim ; Yilmaz, Ebru ; Acar, Mustafa Burak ; Gumus, Hakan ; Haskologlu, Zehra Sule

100 Deals associated with Ankara University

Login to view more data

100 Translational Medicine associated with Ankara University

Login to view more data